StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Abbott Laboratories
NYSE:ABT
Sector
Location
Market Cap
USD 232.62 B
Share Price
USD 133.36
Avg Daily Volume
6,591,886
Change (1 day)
-0.25%
Change (1 year)
30.59%
Change (YTD)
17.90%
Abbott Laboratories Total Assets for the year ending December 31, 2024: USD 81.41 B
Abbott Laboratories Total Assets is USD 81.41 B for the year ending December 31, 2024, a 11.20% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Abbott Laboratories Total Assets for the year ending December 31, 2023 was USD 73.21 B, a -1.64% change year over year.
-
Abbott Laboratories Total Assets for the year ending December 31, 2022 was USD 74.44 B, a -1.01% change year over year.
-
Abbott Laboratories Total Assets for the year ending December 31, 2021 was USD 75.20 B, a 3.65% change year over year.
-
Abbott Laboratories Total Assets for the year ending December 31, 2020 was USD 72.55 B, a 6.87% change year over year.
Competitors
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
GE HealthCare Technologies Inc.
USD 75.20
GEHC
+0.59
0.79%
Laboratory Corporation of America Holdings
USD 257.45
LH
-0.42
-0.16%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.02
0.21%
Globus Medical, Inc.
USD 56.60
GMED
+0.63
1.13%
Indegene Limited
USD 6.60
INDGN.NS
+0.05
0.72%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Danaher Corporation
USD 200.68
DHR
+1.05
0.53%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
GE HealthCare Technologies Inc.
USD 75.20
GEHC
+0.59
0.79%
Laboratory Corporation of America Holdings
USD 257.45
LH
-0.42
-0.16%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.35
603392.SS
+0.02
0.21%
Globus Medical, Inc.
USD 56.60
GMED
+0.63
1.13%
Indegene Limited
USD 6.60
INDGN.NS
+0.05
0.72%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Thermo Fisher Scientific Inc.
USD 426.17
TMO
+7.47
1.78%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
Danaher Corporation
USD 200.68
DHR
+1.05
0.53%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%